Treatments

Treatments

AML Treatment: Benefits of Avoiding High-Dose Chemotherapy

Should AML patients stay away from intensive chemotherapy? Watch as Dr. Daniel Pollyea discusses treatment toxicities, research advances and where AML chemotherapy fits in.

Daniel Pollyea, MD, Andrew Schorr

Treatments

What Is the Treatment Approach for Patients With Secondary AML?

What is the course of care for people who develop secondary AML? Tune in to hear expert Dr. Uma Borate discuss disease presentation, treatment strategy and more.

Uma Borate, MD, MS, Andrew Schorr

Latest News

Treatments

Improving Response and Expanding AML Treatment Options

Uma Borate, MD, MS, Andrew Schorr, Amer Zeidan, MBBS, MHS, Hetty Carraway, MD, Eunice Wang, MD, Harry Kuligofski

Treatments

61st ASH Annual Meeting & Exposition

Treatments

Treatment Options for Newly Diagnosed AML

Gail J. Roboz, MD, Carol Preston

Treatments

Acute Myeloid Leukemia: Your AML, Your Treatment, Your Decision

Pinkal Desai, MD, MPH, Tapan M. Kadia, MD, Jerry Brennan

Treatments

Post-ASCO 2019: Identifying and Treating AML Genetic Subtypes

Eytan Stein, MD, Andrew Schorr

Treatments

AML Expert Dr. Garcia-Manero Discusses New AML Research

Guillermo Garcia-Manero, MD, Andrew Schorr

Treatments

Finding a Match for AML Therapy: How Are Genetic Test Results Used?

Uma Borate, MD, MS, Andrew Schorr

Treatments

Genetic Subtypes for AML: How Does Mutational Status Influence Care?

Amanda Fowler, Uma Borate, MD, MS, Andrew Schorr

Treatments

Ask the AML Expert: What Do New Drugs Mean for My AML?

Daniel Pollyea, MD, Andrew Schorr

Treatments

How Is the AML Treatment Landscape Evolving?

Michelle Rajotte, LMSW, Thomas LeBlanc, MD, Beth Kart Probert

Treatments

What Are the Current Treatment Options for AML?

Amanda Fowler, Don Armstrong, Uma Borate, MD, MS, Andrew Schorr

Treatments

How Can AML Patients Get Involved With Clinical Trials?

Leah Szumita, MS, RN, Beth Kart Probert

Find a clinical trial

Learn More